The role of anaerobic bacteria in abscess formation.
D000005:Abdomen; D000038:Abscess / Q000209:etiology*; D000693:Anaerobiosis; D000818:Animals; D001427:Bacterial Toxins / Q000494:pharmacology; D001442:Bacteroides Infections / Q000188:drug therapy / Q000276:immunology; D001441:Bacteroides fragilis / Q000276:immunology / Q000472:pathogenicity; D002981:Clindamycin / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008050:Lipid A / Q000494:pharmacology; D008795:Metronidazole / Q000627:therapeutic use; D051381:Rats; D014774:Virulence
D001427:Bacterial Toxins; D008050:Lipid A; D008795:Metronidazole; D002981:Clindamycin; D007612:Kanamycin